News, statements & more

Welcome to our pressroom

On this page you will find our latest news items and company statements. If you are looking for images we can provide you access to our image library.

Latest news

October 21, 2019

SurgiMab Recruits First US Patient in Pivotal Phase 3 Trial Evaluating SGM-101, a Novel Fluorescent…

SGM-101 is an investigational new imaging agent for fluorescence-guided surgery designed to enable surgeons to better visualize tumor tissues in real-time   MONTPELLIER, France, Oct. 17, 2019 /PRNewswire/ -- SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach…
October 21, 2019

Positive Phase 2 Study Results Published for On Target's Intraoperative Cancer Imaging Agent

Journal Reports OTL38 Reveals Undetected Cancer in 48% of Patients   WEST LAFAYETTE, Ind., Oct. 15, 2019 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted imaging agents to improve cancer surgery, today announced that its…
July 16, 2019

SurgiMab advances SGM-101, a novel fluorescent tumor-specific antibody, into pivotal Phase 3 clinical trial to…

SGM-101 has the potential to be the first tumor-targeted fluorescent probe to be marketed for fluorescence-guided surgery (FGS)   Montpellier, France, 16 July 2019: SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach designed to improve cancer surgery…

Company statements

Vision Statement:
"Increase our market share and become the Industry Leader and partner for improving patient outcomes by using the latest in optical imaging, big data and image analysis, and out of the box business models."


Mission Statement:

"Provide surgeons with optical imaging tools to improve patient care, reduce costs to society and reduce the environmental footprint. Making the Invisible Visible."


Quality Policy:

"At Quest our quality management focusses on the optimally effective and efficient provision of products, services, support and development required by our clients, patients and other stakeholders."

May 24, 2019

Quest strategic direction statement

Quest is the leader in multi-sensor medical imaging systems for fluorescence image guided surgery.  Through its network of distributors and own subsidiaries, Quest is serving its customers with state of the art technology to improve patient care by using the…

Access image library

Feel free to create an account and access our image library.

Headquarters

Quest Medical Imaging BV

Industrieweg 41

1775 PW Middenmeer

The Netherlands

T: + 31 227 60 40 46

E:  

France

Quest Medical Imaging SAS

Parc eurasante

70 Rue du Docteur Yersin,

59120 Loos les Lille, France

T: + 33 (0)6 89 41 66 81 

E:  

North America

Quest Med­ical Imag­ing Inc.

2711 W. Market St

Suite 13589,

Akron, Ohio 44333 U.S.A.

T + 1 330 752 6596

F + 1 330 752 6597

E:  

Germany

Quest Medical Imaging Germany

Stolzestraße 24

44789 Bochum, Germany

T: + 49 234 54 44 41 84

E:  

fda cleared ce iso